Technology matters: The clinical utility of HPV mRNA testing compared to DNA testing

Article

Developments in cervical cancer screening have dramatically decreased disease incidence and mortality over the past few decades - but have also added confusion concerning the roles and clinical applications of new technologies that detect human papillomavirus (HPV). How should clinicians approach these new testing methods so that they can provide better quality of life and treatment planning for their patients?

In this online supplement, E. Marshall Austin, MD, PhD offers insights on the many questions clinicians may have about HPV testing modalities, including:

  • What is the role of HPV in cervical cancer?
  • How do performance data compare for HPV DNA and mRNA tests?
  • What are the benefits of HPV mRNA testing?

Read this online supplement to learn more about the latest in developments in cervical cancer screening.

Download Supplement

 

 

Recent Videos
Baher Mankabady, MD, highlights safety of buprenorphine against OUD in pregnancy | Image Credit: linkedin.com.
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
© 2025 MJH Life Sciences

All rights reserved.